The benefits of exercise in progressive MS: some cautious optimism

Feinstein, Anthony; Dalgas, Ulrik
March 2014
Multiple Sclerosis Journal;Mar2014, Vol. 20 Issue 3, p269
Academic Journal
The authors reflect on the benefits of exercise in progressive multiple sclerosis (MS). Particular focus is given to a study on the benefits offered by different aerobic exercise modalities, which was identified by the authors as timely and important. Among of the benefits offered by exercise are improving certain aspects of cognition and enhancing mood. The authors emphasize the need for replication and increase of sample sizes.


Related Articles

  • Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial. Briken, S; Gold, SM; Patra, S; Vettorazzi, E; Harbs, D; Tallner, A; Ketels, G; Schulz, KH; Heesen, C // Multiple Sclerosis Journal;Mar2014, Vol. 20 Issue 3, p382 

    The article presents a study which investigates the potential of standardized exercise to function as a therapeutic intervention for progressive multiple sclerosis (MS) through a randomized, controlled pilot trial. Details about the methods of the study are provided. The study suggests aerobic...

  • Fingolimod finds favour in MS.  // PharmacoEconomics & Outcomes News;10/4/2008, Issue 563, p9 

    The article focuses on a phase II study, presented at the World Congress on Treatment and Research in Multiple Sclerosis, which showed that oral fingolimod may improve health-related (HR) quality of life (QOL) among patients with relapsing multiple sclerosis (MS). 281 patients who were...

  • Training for better glycaemic control.  // Active Living;Jan2011, Vol. 20 Issue 1, p16 

    The article discusses the finding of a clinical trial which investigates the effect of aerobic and resistance training on glycemic control.

  • Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Lily, O.; McFadden, E.; Hensor, E.; Johnson, M.; Ford, H. // Multiple Sclerosis (13524585);Dec2006, Vol. 12 Issue 6, p808 

    Disease specific quality of life was measured in the Leeds Multiple Sclerosis (MS) Treatment Programme (n = 210) using the self-report Leeds MS Quality of Life (LMSQoL) scale. The results showed a significant and sustained increase in quality of life associated with 'disease modifying'...

  • Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. Phillips, J. Theodore; Giovannoni, Gavin; Lublin, Fred D.; O’Connor, Paul W; Polman, Chris H.; Willoughby, Ernie; Aschenbach, William; Pace, Amy; Hyde, Robert; Munschauer, Frederick E. // Multiple Sclerosis Journal;Aug2011, Vol. 17 Issue 8, p970 

    Background: Validated measures of sustained improvements in neurological function have not been established for multiple sclerosis (MS) clinical studies.Objective: To evaluate sustained Expanded Disability Status Scale (EDSS) change as a potential indicator of neurological improvement and as an...

  • Measuring the Quality of Life in Patients with Multiple Sclerosis in Clinical Practice: A Necessary Challenge. Baumstarck, Karine; Boyer, Laurent; Boucekine, Mohamed; Michel, Pierre; Pelletier, Jean; Auquier, Pascal // Multiple Sclerosis International;2013, p1 

    While the physical disability aspect of multiple sclerosis (MS) is of great importance, quality of life (QoL) measurements are being considered increasingly important with regard to evaluating disease progression, treatment, and the management of care provided toMS patients. Despite the...

  • Promising results in early Antegren trial.  // Inside MS;Winter2002, Vol. 20 Issue 1, p36 

    Reports on the result of an early double-blind clinical trial of Antegren as announced at the 7th Congress of the European Committee on Treatment and Research in Multiple Sclerosis on September 15, 2001. Number of multiple sclerosis patients who participated in the trial; Effects of Antegren;...

  • One face behind the numbers. Yusuf, Katharine // American Journal of Health-System Pharmacy;11/1/2009, Vol. 66 Issue 21, p1955 

    A personal narrative is presented which explores the author's experience of participating in a clinical trial to cure her multiple sclerosis.

  • Will treatment make life better?  // Inside MS;Fall95, Vol. 13 Issue 3, p10 

    Discusses the necessity of balancing clinical benefits, side effects and quality of life in choosing a therapy for patients with multiple sclerosis (MS). Adaptation of cancer and AIDS quality-of-life evaluations to MS; Measurement of emotional well-being.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics